Publications by authors named "Isao Yoshida"

Claim this Profile
F
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.
Ken Ohmachi, Tomohiro Kinoshita, Dai Maruyama, Ryunosuke Machida, Yusuke Sano, Isao Yoshida, Shinichiro Yoshida

Jpn J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.
Toshiki Terao, Isao Yoshida, Hiroki Kobayashi, Tomohiro Urata, Fuminari Fujii

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.
Kenta Hayashino, Nobuharu Fujii, Satsuki Murakami, Taro Masunari, Isao Yoshida

Clin Lymphoma Myeloma Leuk· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL.
Jun Takizawa, Isao Yoshida, Yoshiaki Ogawa, Tomomi Toubai, Shigeru Kusumoto

Int J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma.
Noriko Fukuhara, Isao Yoshida, Takuro Ishiguro, Katsuya Fujimoto, Junya Kuroda

Cancer Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex amplicon sequencing for the comprehensive genotyping of .
Hiroaki Kubota, Rumi Okuno, Tsuyoshi Kenri, Yumi Uchitani, Tsukasa Ariyoshi, Isao Yoshida

Microbiol Spectr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, double-blind, placebo-controlled trial of the Kampo formula daiobotanpito combined with antibiotic therapy for acute diverticulitis.
Keiko Ogawa-Ochiai, Shigetsugu Tsuji, Atsuki Maeda, Hisatomo Ikehara, Kazumi Kawabata, Isao Yoshida

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma3. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia (LPL/WM).
Isao Yoshida

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma-2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associated lymphoid tissue], nodal marginal zone lymphoma: NMZL, splenic marginal zone lymphoma: SMZL).
Isao Yoshida

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Masaki Ri, Shinsuke Iida, Kosuke Saito, Yoshiro Saito, Dai Maruyama, Shinichiro Yoshida, Isao Yoshida

Cancer Chemother Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Takeo Kuwata, Yu Kaku, Shashwata Biswas, Kaho Matsumoto, Mikiko Shimizu, Isao Yoshida

EBioMedicine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of giardiasis diagnosed from a high output stoma after surgery for obstructive colorectal cancer].
Isao Yoshida, Takahiro Matsumura, Hironori Shimizu, Fumiyo Iida, Toshiaki Yasui

Nihon Shokakibyo Gakkai Zasshi· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of EBV-associated adrenal leiomyoma.
Takumasa Takemoto, Ikuko Kiriyama, Yoshifumi Sugawara, Chie Abe, Norihiro Teramoto, Isao Yoshida

Radiol Case Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Tomohiro Urata, Yusuke Naoi, Aixiang Jiang, Merrill Boyle, Kazutaka Sunami, Isao Yoshida

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida, Tomoko Kataoka, Noriyasu Fukushima, Isao Yoshida

Hematol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Characteristics of the Virus Detected in the First Mpox Imported Case in Tokyo, Japan.
Fumi Kasuya, Akane Negishi, Ryota Kumagai, Isao Yoshida, Kou Murakami

Jpn J Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Kana Miyazaki, Rika Sakai, Noriko Iwaki, Go Yamamoto, Kayoko Murayama, Isao Yoshida

Cancer Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group.
Yuki Fujiwara, Tomohiro Urata, Daigo Niiya, Tomofumi Yano, Yuichiro Nawa, Isao Yoshida

Int J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Nobu Akiyama, Takuho Okamura, Minoru Yoshida, Shun-Ichi Kimura, Shingo Yano, Isao Yoshida

Support Care Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants.
Mikako Ueno, Naoko Iwata-Yoshikawa, Akihiro Matsunaga, Tadashi Okamura, Sho Saito, Isao Yoshida

Antiviral Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA Detection Using RT-qPCR and Non-Isolation of SARS-CoV-2 in Concentrated Wastewater (June-August 2020, Tokyo).
Mami Nagashima, Mamiyo Kawakami, Masaki Hayashi, Ryota Kumagai, Fumi Kasuya, Isao Yoshida, Hiromu Yoshida

Jpn J Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Akatsuki Saito, Takashi Irie, Rigel Suzuki, Tadashi Maemura, Hesham Nasser, Isao Yoshida

Nature· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study on Viral Load in Stool Samples of Patients with COVID-19 Suffering from Diarrhea.
Yutaro Akiyama, Noriko Kinoshita, Kenji Sadamasu, Mami Nagashima, Isao Yoshida

Jpn J Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial.
Akiko M Saito, Isao Yoshida, Shiro Tanaka, Morio Sawamura, Michihiro Hidaka, Shinichiro Yoshida

Kurume Med J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Petra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Isao Yoshida

Nature· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis